Abstract:Background For IgA nephropathy (IgAN), tubular atrophy/interstitial fibrosis is the most important prognostic pathological indicator in the mesangial and endocapillary hypercellularity, segmental sclerosis, interstitial fibrosis/tubular atrophy, and presence of crescents (MEST-C) score. The identification of non-invasive biomarkers for tubular atrophy/interstitial fibrosis would aid clinical monitoring of IgAN progression and improve patient prognosis. Methods The study included 188 patients with primary IgAN in separate confirmation and validation cohorts. The associations of miR-92a-3p, miR-425-5p, and miR-185-5p with renal histopathological lesions and prognosis were explored using Spearman correlation analysis and Kaplan-Meier survival curves. Bioinformatics analysis and dual luciferase experiments were used to identify hub genes for miR-185-5p. The fibrotic phenotypes of tubular epithelial cells were evaluated in vivo and in HK-2 cells. Results miRNA sequencing and cohort validation revealed that the expression levels of miR-92a-3p, miR-425-5p, and miR-185-5p in urine were significantly increased among patients with IgAN; these levels could predict the extent of tubular atrophy/interstitial fibrosis in such patients. The combination of the three biomarkers resulted in an area under the receiver operating characteristic curve of 0.742. The renal prognosis was significantly worse in the miR-185-5p high expression group than in the low expression group (P=0.003). Renal tissue in situ hybridization, bioinformatics analysis, and dual luciferase experiments confirmed that miR-185-5p affects prognosis in patients with IgAN mainly by influencing expression of the target gene tight junction protein 1 (TJP1) in renal tubular epithelial cells. In vitro experiment revealed that an miR-185-5p mimic could reduce TJP1 expression in HK-2 cells, while increasing the levels of α-smooth muscle actin, fibronectin, collagen I, and collagen III; these changes promoted the transformation of renal tubular epithelial cells to a fibrotic phenotype. An miR-185-5p inhibitor can reverse the fibrotic phenotype in renal tubular epithelial cells. In a unilateral ureteral obstruction model, the inhibition of miR-185-5p expression alleviated tubular atrophy/interstitial fibrosis. Conclusion Urinary miR-185-5p, a non-invasive biomarker of tubular atrophy/interstitial fibrosis in IgAN, may promote the transformation of renal tubular epithelial cells to a fibrotic phenotype via TJP1.

MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis

Mesangial Cell–Derived Exosomal Mir-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2

MicroRNA-21-5p Participates in IgA Nephropathy by Driving T Helper Cell Polarization

Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis

Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression

MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy.

MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin 4 and 5 in IgA nephropathy

Inhibition of Mirna-21 Prevents Fibrogenic Activation in Podocytes and Tubular Cells in IgA Nephropathy

Proteins induced by telomere dysfunction are associated with human IgA nephropathy.

Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy

Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy

MTMR3 risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy

Single-Cell Transcriptomics Reveal Immune Mechanisms of the Onset and Progression of IgA Nephropathy.

B Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis

MiR-133a/133b Inhibits Treg Differentiation in IgA Nephropathy Through Targeting FOXP3.

A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy

LncRNA PTTG3P induced aberrant glycosylated IgA1 production and B cell growth in IgA nephropathy

<i>MTMR3</i> risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy